Back to news index
South Korean Prime Minister Hwang Kyo-Ahn on Tuesday declared the deadly outbreak of Middle East Respiratory Syndrome (MERS) was over, Yonhap news agency reported. Thirty-six people died out of the 186 infected in the MERS outbreak, the biggest of the virus outside Saudi Arabia, following the first diagnosis on May 20. "After weighing various circumstances, the medical personnel and the government judge that the people can now be free from worry," Hwang said in a meeting with government officials, Yonhap reported.
U.S. Navy investigates report of cancer cluster at Guantanamo
The U.S. Navy is investigating a complaint that seeks the evacuation of civilian and military lawyers from parts of the U.S. base in Guantanamo Bay, Cuba, following reports of cancer cases among personnel working on the trials of detainees there. At least seven civilians and military members who worked on detainee trials at Guantanamo Bay have been diagnosed with cancer, according to the complaint, which was filed with the U.S. Defense Department’s Office of the Inspector General. The complaint claims that an unusually large number of relatively healthy and young people who worked at the base have been diagnosed with cancer.
A dengue vaccine candidate by French drugmaker Sanofi protects more than three quarters of participants, an analysis found Monday. The experimental drug allowed 80.8 percent of children aged nine and older to avoid hospitalization, according to three trials analyzed by the New England Journal of Medicine. For younger children, those less than nine years old, vaccine efficacy was 56.1 percent.
By Keith Coffman DENVER (Reuters) - The younger sister of Colorado movie massacre gunman James Holmes testified at his trial for the first time on Monday, telling jurors who will decide his fate that the murders were completely out of character, and she still loves him. Chris Holmes, 22, was called by the defense during the punishment phase of the trial.
Mylan independence from Teva's embrace comes with a price
Teva announced a $40.5 billion deal for the generic assets of Allergan Plc after an unsuccessful three-month attempt to bring Mylan to the table. Mylan, whose shares fell 14.5 percent, said it would continue its own unsolicited pursuit of Irish drugmaker Perrigo Co, a maker of over-the-counter consumer and nutritional products and generic topical medicines. Perrigo is one of the few remaining assets out there," said Morningstar analyst Michael Waterhouse.
Planned Parenthood investigating claims of website hack
Planned Parenthood called on the FBI and the U.S. Department of Justice on Monday for help managing cybersecurity, following a report that the reproductive healthcare group's website had been hacked by anti-abortion activists. The organization has come under scrutiny since the release of two secretly recorded videos earlier this month that critics said showed it was involved in the illegal sale of aborted fetal tissue for medical research. The Daily Dot online newspaper reported Monday that a hacking group had gained access to Planned Parenthood's website databases and the names and email addresses of its employees.
Have you ever been just into your first set of lateral raises and felt a pinching feeling? What about being halfway through your run and your knee starts to hurt? What do you do? Do you press through or stop?There are very few of us that don't deal with injuries or niggles of some sort. So how can we prevent and manage injuries so that they...
Israel’s Teva Pharmaceutical Industries will pay $40.5 billion in cash and stock for Allergan’s generic drugs business, solidifying Teva's position as the world's No. 1 maker of generics while freeing Allergan to focus on branded drugs, paying down debt and potential "transformational" acquisitions. The deal, the largest in Israel's corporate history, allows Teva stronger economies of scale, crucial in the low-margin generic drugs business. Teva, which dropped its hostile pursuit of Mylan, will likely have to sell off some drugs to allay antitrust concerns.
Allergan CEO, fresh off one deal, sets sights on others
Allergan plc CEO Brent Saunders is ready to put the $36 billion his company will net from the sale of its generics business to Teva Pharmaceutical Industries Ltd to work, possibly with another large, "transformational" merger. The readiness for a new transaction just after the Teva deal was announced on Monday represents what Saunders calls a strategy to remain nimble and open to opportunity as the healthcare sector remakes itself. Just last year, he helped orchestrate the $25 billion sale of Forest Laboratories Inc, where he was CEO, to Actavis Plc.
"This is going to be hard""This is going to 'suck'""I'm going to have a terrible time""I'm dreading going to work" Sound familiar?When we approach something with drudgery, what happens?Our expectations never fail us, do they?I think, many times, we create these scenarios by accident or based on previous experiences. And, worse yet, we may even...
Primary care doctors should screen for depression: panel
By Andrew M. Seaman (Reuters Health) - U.S. adults should be screened for depression, according to a proposal from a government-backed panel of medical experts. With this proposal, the U.S. Preventive Services Task Force broadens its 2009 recommendation that adults be screened in doctors' offices if staff-assisted depression care is available. "We believe all clinical practices should be able to put those systems in place," said Dr. Kirsten Bibbins-Domingo, the USPSTF's co-vice chair.
As I was making the masala mixture to fill the green chilies with, I asked my grandmother if I need to add two small 'kharchas' of oil, at which my mother laughed. I realized quickly that the added 'h' changed the meaning entirely. While kharcha or kharcho refers to cost or price of something, a karchho is a ladle. Pronunciation in Gujarati is...
Lessons From the Gym for the Over-50 Crowd
Two years ago, I lost 50 pounds. I've gained back about five or six, which doesn't make me happy, but isn't a tragedy. About a year ago, I decided to start a personal training regimen -- not to keep the weight off, because I fundamentally believe that has more to do with eating less than with exercise -- but to feel stronger and more competent...
Young cancer patients may be unaware of fertility options
By Lisa Rapaport (Reuters Health) - Young cancer patients, often left infertile after treatment, may be unaware of ways to preserve their options for having children, a study suggests. Out of 459 adolescents and young adults diagnosed with cancer in 2007 or 2008, more than 70 percent said doctors had explained their risk of infertility. Patients who already had children were also less likely to explore fertility preservation than those who didn’t have children, the study found.
I finally took the plunge.After months of reading up on the pros and cons of juicing and following enlightened advocates like Kris Carr and Joe Cross, I decided to give it a try.First I had to find the juicer. My husband, David, had purchased a Breville when I was diagnosed with breast cancer six years ago thinking we (he) would juice my way...
Drugmakers have delayed reporting serious and unexpected "adverse events" from their drugs, including death, in nearly 10 percent of cases, a study said Monday. US regulations require drugmakers to report such incidents to the Food and Drug Administration within 15 days, but researchers at the University of Minnesota found that they delayed doing so in about one in 10 cases. "Strikingly, AEs (adverse events) with patient death were more likely to be delayed," the study's authors said.
Ireland to hand adopted people birth records for first time
By Padraic Halpin DUBLIN (Reuters) - Ireland will allow tens of thousands of adopted people access to their birth certificates for the first time under proposed legislation that some advocacy groups say could still deprive many of their identities. International laws say all children should be able to establish their identity but adopted people in Ireland, many of whom were sent for adoption in secret by Catholic institutions, have no automatic right to their birth records or access to tracing services. Successive governments had argued that a 1998 Supreme Court ruling prevented them from opening adoption files because it emphasized the mother's right to privacy.
European Union nations have until August 20 to suspend the sale of some 700 generic drugs made in India, the EU's executive confirmed on Monday. The European Commission took the action after an Indian firm contracted by drug companies to test the medications was found to have manipulated data. On-site verifications last year at GVK Biosciences showed irregularities "in each and every one of the nine trials inspected," the European Medicines Agency said in a May report recommending the suspension.
Alstom is to accept 300 million euros ($333 million) less than previously agreed for its power turbines unit from General Electric as a contribution to the U.S.-based buyer's efforts to win antitrust clearance in Europe. The last-minute 2.4 percent discount to the previously agreed 12.35 billion euro deal is the latest in a series of knocks Alstom shareholders have suffered since the deal was announced in April 2014. "In order to support General Electric in its offering of a comprehensive set of remedies addressing the concern of the(European) Commission, Alstom's board... would contribute financially to such remedy package through a reduction of 300 million euros," the French engineering company said in a statement.
UK checking two suspected MERS cases in northern England
By Kate and Kelland LONDON, July 27 (Reuters) - Health officials were investigating two suspected cases of the Middle Eastern Respiratory Virus Syndrome (MERS) on Monday at a hospital in northern England that briefly closed its emergency department. The two suspected patients at Manchester Royal Infirmary were placed in isolation, but there was no significant risk to others at the hospital or to the general public, Central Manchester University Hospitals Trust said. "Manchester Royal Infirmary A&E is open to the public.
By Andrew M. Seaman (Reuters Health) - Teens are more likely to use electronic cigarettes if their friends and family view them as cool or acceptable, a new study suggests. "There is a lot of concern by the public health community that e-cigarettes may be recruiting a whole new group of people who never smoked cigarettes," said lead author Jessica Barrington-Trimis of the University of Southern California in Los Angeles. Previous studies have found links between use of traditional and electronic cigarettes, Barrington-Trimis said.
By: Linsley Oaks, LuxEco Living Editorial AssistantI love food. I mean, I really love food. Good food. This is no puppy dog love relationship: it is a border line obsession. Growing up, I was spoiled: my dad was a French trained chef while he was in college, and my family reaped all the benefits from his expertise in the kitchen. I didnʼt even...
Not all new mothers in U.S. get advice on breastfeeding, infant care: survey
Despite medical evidence showing the benefits of breastfeeding and how to prevent cot deaths, some doctors are not passing on the information to new mothers in the United States, researchers said on Monday. In a survey of more than 1,000 new mothers funded by the National Institutes of Health, they found that about 20 percent of women did not receive guidance on breastfeeding or on placing infants to sleep on their backs to reduce the risk of sudden infant death syndrome (SIDS). "As a physician, these findings made me stop and really think about how we communicate important information to new patients," said Dr. Staci R. Eisenberg, a pediatrician at Boston Medical Center and the first author of the study, published in the journal Pediatrics.
Sanofi says new data analyses support its dengue vaccine
French drugmaker Sanofi said on Monday that new data analyses published in the New England Journal of Medicine confirmed that its vaccine candidate against dengue protected two-thirds of the participants in two late-stage studies. Protection against severe dengue reached 93 percent, while prevention of hospitalization due to the disease reached 80 percent in the volunteers, who were aged nine and above, Sanofi said in a statement. "The dengue vaccine candidate has the potential to significantly reduce disease burden in endemic countries," Sanofi said.
Bellerophon shares plummet after heart drug fails in study
Bellerophon Therapeutics Inc's shares plummeted more than 60 percent on Monday after the company said an injectable heart drug it is developing under license failed in a study. The drug, bioabsorbable cardiac matrix, was licensed from BioLineRx Ltd in 2009 after animal studies showed that it acted as a "scaffold" to support the heart wall and was likely to prevent further structural damage. When BCM is administered after a heart attack, it flows into the damaged heart muscle where it forms a protective layer.
Some serious drug side effects not told to FDA within 15 days
By Lisa Rapaport (Reuters Health) - Companies fail to report roughly one in 10 serious and unexpected medication side effects to the U.S. Food and Drug Administration (FDA) within a 15-day window specified by federal regulations to protect patient safety, a study finds. Drug manufacturers are also less likely to disclose serious adverse events within this window when patient deaths are involved than when complications aren’t fatal, according to an analysis of 1.6 million side effect reports to the FDA from 2004 to 2014.
Proper sleeping positions, breastfeeding, vaccinations and pacifier use are aspects of infant care that new moms should be advised on, according to a new study. Working with a total of 1,000 new moms, researchers from the UK's National Institutes of Health found that approximately 20 percent of mothers do not receive advice from doctors about how to care for their babies.
Testosterone fails to help with ejaculation problems
By Kathryn Doyle (Reuters Health) - In a four-month trial, testosterone therapy did not improve ejaculation problems in men with low testosterone levels. “We wanted to explore in this study whether testosterone replacement is beneficial in the treatment of ejaculatory dysfunctions in men with low serum testosterone levels,” said senior author Dr. Shehzad Basaria of Brigham and Women’s Hospital in Boston. Sexual dysfunction in men generally falls into three categories, Basaria told Reuters Health: problems with libido, problems with erections and problems with ejaculation.
Germany culls 10,000 hens after confirmed bird flu case
German authorities have slaughtered around 10,000 hens after a case of bird flu was confirmed at a poultry farm in the northwestern state of Lower Saxony, the state's agriculture ministry said on Monday. Germany's animal health body, the Friedrich Loeffler Institute, confirmed the case as high pathogenic H7N7 bird flu. Lower Saxony, a leading poultry production region, reported outbreaks of the H5N8 strain of bird flu in December, as well as cases of the milder, "low pathogenic" form of the H7N7 strain in March and June this year.
Lilly continues test of HDL cholesterol drug, on panel's advice
(Reuters) - Eli Lilly and Co on Monday said it would continue a large study of its high-profile experimental drug to raise "good" HDL cholesterol and lower "bad" LDL cholesterol, acting on the recommendation of a data monitoring committee. The independent panel of scientific advisors made its recommendation after taking an interim look at data from the Phase III study of the medicine, called evacetrapib, and assessing whether the trial had potential of attaining its primary goals, Lilly said. Lilly said it expects to complete the 12,095-patient study, called ACCELERATE, in 2016.
Case of low-risk H7N7 bird flu found at German poultry farm
A case of the low-risk bird flu strain H7N7 has been found on a poultry farm in Emsland in north Germany, the state of Lower Saxony said on Monday. The 10,000 egg-laying hens on the farm have been culled, the state's agriculture ministry said in a statement. The H7N7 bird flu strain was also confirmed at a farm in England on July 13.
Photo credit: Getty Images Health complaints change over the decades. What worries us at 25 is very different from our concerns at 40. We asked the HuffPost Lifestyle Facebook community to tell us what they worried about most, and then conferred with experts. Whether you're barely 20 years old or pushing 65, health stewardship is a part of...
By Tom Miles GENEVA (Reuters) - The United Nations hopes to massively scale up aid to Aden now that fighting has all but stopped in the Yemeni port city, the U.N. official in charge of humanitarian aid to Yemen said after a weekend trip to the city. Johannes van der Klaauw said he saw bodies lying in the street and whole districts damaged or destroyed, but the battle between the Houthi militia and local fighters backed by a Saudi-led air campaign had moved north. "There are still some snipers on the (Aden) peninsula – the Houthis have not all withdrawn apparently.
By Joe Brock JOHANNESBURG (Reuters) - From milk churning in Zimbabwe to rose growing in Ethiopia, private equity investments in Africa have returned to pre-crisis levels and should keep rising as funds seek bumper returns in far-flung markets. Private equity deals in Africa totalled $8.1 billion last year, the second highest on record after the $8.3 billion posted in 2007, according to the African Private Equity and Venture Capital Association (AVCA). This year could be even bigger as investors tired of low returns in developed markets look to cash in on the rapidly emerging middle-class consumers in Africa - home to many of the fastest growing economies in the world.
New heart drugs come in more expensive than expected
Praluent, made by Sanofi and Regeneron Pharmaceuticals, and Entresto from Novartis are both treatments that represent significant advances for millions of patients at risk of serious heart problems. The manufacturers have taken an ambitious view on pricing, arguing that the clear medical benefits of their products and their ability to keep patients out of expensive hospital beds, make them cost-effective choices for healthcare providers. Sanofi and Regeneron, which won U.S. approval on Friday for Praluent to treat stubbornly high cholesterol, said the injection would cost $14,600 a year, well above the roughly $10,000 investors had expected.
AstraZeneca , under pressure from falling sales of older drugs, is selling a medicine for a rare type of cancer to Sanofi as it continues a drive to raise cash by divesting certain assets. Sanofi's rare diseases division Genzyme will pay AstraZeneca up to $300 million for global rights to Caprelsa, including an upfront payment of $165 million and milestone payments based on the drug's performance of up to $135 million, the companies said on Monday. AstraZeneca, which said the transaction was expected to complete in the second half of 2015 and would not impact its financial forecasts for the year, said Caprelsa was better suited for a rare disease specialist such as Genzyme.
By Joseph D'Urso LONDON (Thomson Reuters Foundation) - Investment banking doesn't rank highly on most people's lists of ethical career choices, but according to one of the world's most famous living philosophers, becoming a hot shot in finance may be the best way for a bright graduate to help the global poor. A high earner in the corporate world who is giving away large sums can create more social gain than if they did charity work, said Peter Singer, who teaches at Princeton University. "If they are able to live modestly and give a lot away, they can save many lives," he told the Thomson Reuters Foundation.
As he manoeuvres his taxi through the barely moving traffic of downtown Yangon, Myo Min Htaike's jaw methodically pounds a pulpy mass of nuts and tobacco, his teeth stained a dark blood-red. Plying his trade in the seemingly eternal gridlock of Myanmar's now booming commercial hub, he is more than used to spending long days on the roads and "kun ja" -- better known as betel nut or quid -- is the one thing that keeps him going. Kun ja is an enormously popular stimulant chewed throughout Myanmar.
By Rich McKay ATLANTA (Reuters) - Bobbi Kristina Brown, the only child of late singer Whitney Houston, died on Sunday at the age of 22, some six months after suffering irreversible brain damage in an incident at her suburban Atlanta home, her family said in a statement. Brown, whose father is R&B singer Bobby Brown, was found face down and unresponsive in a bathtub in her home by her partner and a friend on Jan. 31.